We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

184 hedge funds and large institutions have $744M invested in SANGAMO THERAPEUTICS INC in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

23% more call options, than puts

Call options by funds: $14.9M | Put options by funds: $12.1M

1.73% more ownership

Funds ownership: 69.25% → 70.98% (+1.7%)

1% less funds holding

Funds holding: 185 → 184 (-1)

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

14% less capital invested

Capital invested by funds: $860M → $744M (-$116M)

Holders
184
Holders Change
-1
Holders Change %
-0.54%
% of All Funds
4.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
59
Reduced
41
Closed
25
Calls
$14.9M
Puts
$12.1M
Net Calls
+$2.81M
Net Calls Change
-$7.64M

Top Buyers

Rank Fund Capital Flow
1
MWNA
Marshall Wace North America
New York
+$11.6M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$6.07M
3
Jennison Associates
Jennison Associates
New York
+$5.78M
4
Morgan Stanley
Morgan Stanley
New York
+$4.21M
5
WA
Wasatch Advisors
Utah
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$6.28M
2
Deutsche Bank
Deutsche Bank
Germany
-$6.22M
3
State Street
State Street
Massachusetts
-$3.69M
4
SFM
Sphera Funds Management
Israel
-$3.03M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
EW
176
Evoke Wealth
California
$1.41K +$1.75K +156 New
CAC
177
Certified Advisory Corp
Florida
$1K – – –
GWM
178
Geneos Wealth Management
Colorado
$1K – – –
LC
179
Lindbrook Capital
California
$1K – – –
NFG
180
Next Financial Group
Texas
$1K – – –
VFA
181
Valeo Financial Advisors
Indiana
$1K – – –
Rockefeller Capital Management
182
Rockefeller Capital Management
New York
$1K +$1.12K +100 New
IA
183
IFP Advisors
Florida
$1K +$1.78K +159 New
SFM
184
Sphera Funds Management
Israel
– -$3.03M -281,291 Closed
Two Sigma Advisers
185
Two Sigma Advisers
New York
– -$2.13M -197,300 Closed
TCM
186
Tekla Capital Management
Massachusetts
– -$1.3M -120,768 Closed
SAMH
187
Shanda Asset Management Holdings
British Virgin Islands
– -$1.23M -114,410 Closed
CSS
188
Cubist Systematic Strategies
Connecticut
– -$738K -68,478 Closed
LCM
189
Laurion Capital Management
New York
– -$730K -67,787 Closed
FI
190
Fosun International
China
– -$663K -62,808 Closed
SLG
191
Stanley-Laman Group
Pennsylvania
– -$291K -27,059 Closed
Walleye Capital
192
Walleye Capital
New York
– -$244K -22,699 Closed
Balyasny Asset Management
193
Balyasny Asset Management
Illinois
– -$186K -17,264 Closed
WCM
194
Weld Capital Management
New York
– -$180K -16,710 Closed
TSS
195
Two Sigma Securities
New York
– -$177K -16,471 Closed
USAA
196
United Services Automobile Association
Texas
– -$175K -16,243 Closed
CWM
197
Cedar Wealth Management
California
– -$154K -14,270 Closed
AG
198
Aperio Group
California
– -$133K -12,304 Closed
QSS
199
Quantitative Systematic Strategies
Florida
– -$126K -11,742 Closed
Canada Life
200
Canada Life
Manitoba, Canada
– -$116K -10,811 Closed
5 6 7
8
9

SGMO Hedge Fund Activity: Q3 2019 in Review

184 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2019, worth a combined $744M — down 14% from $860M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of SGMO and 24 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 59 added.

The largest buyer was Marshall Wace North America, opening a new position worth an estimated $11.6M. The largest seller was Renaissance Technologies, cutting an estimated $6.28M.

  • 184 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2019, down from 185 in Q2 2019.
  • Funds reported $744M of SANGAMO THERAPEUTICS INC stock for Q3 2019, down 14% quarter-over-quarter.
  • 24 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2019 and 25 closed out, a net change of -1 holder.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2019 was Marshall Wace North America, an estimated $11.6M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2019 was Renaissance Technologies, an estimated $6.28M sold.

Based on aggregated 13F filings for Q3 2019.